Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

March 1, 2027

Conditions
Rare Genetic Muscle DiseasesMuscular Dystrophy, DuchenneMuscular Dystrophy, BeckerCongenital MyopathyPompe Disease (Infantile-Onset)
Interventions
OTHER

ARN extraction from muscle biopsies

"There will be no visits from participants, so we will be using samples already in the Biological Resources Centre (CRB).~RNA will be extracted from muscle biopsies taken as part of the treatment. RNAseq libraries will be sequenced by the Genomics and Bioinformatics Platform (GBiM) at Marseille Medical Genetics (MMG, U1251, AMU). Sequencing will be performed in paired-end (2\*100 bp) on Illumina's Novaseq 6000 system (50 million clusters per sample, 100 M paired-end reads) and then analysed by bioinformatics."

Trial Locations (1)

13005

RECRUITING

Hopital Timone, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER